Lmr Partners LLP Harrow Health, Inc. Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$13.84 - $21.46 $15,459 - $23,970	1,117 Added 10.18%	12,093 $255,000
Q4 2022 Feb 14, 2023	BUY	$10.28 - $14.78 $112,833 - $162,225	10,976 New	10,976 $162,000
Q3 2021 Nov 15, 2021	SELL	$6.99 - $10.6 $86,829 - $131,673	-12,422 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $82,978 - $137,511	12,422 New	12,422 $115,000

176

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.06B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.